|
Trial no.:
|
PACTR201909623653208 |
Date of Registration:
|
30/09/2019 |
|
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
| TRIAL DESCRIPTION |
|
Public title
|
Compartive study of the haemodynamic effects of carbetocin and oxytocin in elective caesarean delivery in preeclamptic patients under spinal anesthesia |
| Official scientific title |
Compartive study of the haemodynamic effects of carbetocin and oxytocin in elective caesarean delivery in preeclamptic patients under spinal anesthesia
|
|
Brief summary describing the background
and objectives of the trial
|
Postpartum haemorrhage (PPH) is a potentially life-threatening complication of both vaginal and caesarean delivery. The most frequent cause of PPH is uterine atony .Intravenous injection of 5 IU of oxytocin is recommended as the medication of choice to reduce the incidence and severity of PPH .Currently 100 μg of carbetocin is routinely used for the prevention of PPH. |
| Type of trial |
RCT |
| Acronym (If the trial has an acronym then please provide) |
PE |
| Disease(s) or condition(s) being studied |
Circulatory System |
| Sub-Disease(s) or condition(s) being studied |
|
| Purpose of the trial |
Diagnosis / Prognosis |
| Anticipated trial start date |
01/09/2019 |
| Actual trial start date |
15/09/2019 |
| Anticipated date of last follow up |
15/12/2019 |
| Actual Last follow-up date |
01/01/2020 |
| Anticipated target sample size (number of participants) |
80 |
| Actual target sample size (number of participants) |
80 |
| Recruitment status |
Recruiting |
| Publication URL |
Not yet decided |
|